Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CUSP-06 by OnCusp Therapeutics for Solid Tumor: Likelihood of Approval
CUSP-06 is under clinical development by OnCusp Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
CUSP-06 by OnCusp Therapeutics for Ovarian Cancer: Likelihood of Approval
CUSP-06 is under clinical development by OnCusp Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
CUSP-06 by OnCusp Therapeutics for Renal Cell Carcinoma: Likelihood of Approval
CUSP-06 is under clinical development by OnCusp Therapeutics and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...